Role of Zasdamrut tablets in the patients with Acute Upper Respiratory Tract Infections (URTI)

An open label randomized comparative clinical study to evaluate the efficacy of Zasdamrut in Acute Upper Respiratory Tract Infections

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/12/047941

Enrollment

Registered

2022-12-07

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J069- Acute upper respiratory infection,unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients of either gender between 18 and 60 years (Both years inclusive) 2 Patients with symptoms on the basis of Jackson Downing URTI scale 3 Those who gives consent and assent as per requirement

Exclusion criteria

Exclusion criteria: 1 Patients with Chronic bronchial asthma 2 Patients with tuberculosis 3 Patients with severe lower RTI (pneumonia, emphysema, bronchiectasis) or associated with other systemic illness

Design outcomes

Primary

Measure	Time frame
Assessment on the basis of Jackson Downing URTI scaleTimepoint: Assessment will be done on day 0, day 3rd or 4th, day 7th and day 14th (without medicine)	—

Secondary

Measure	Time frame
Assessment on the basis of CBC, CRP, AEC, MP (Malarial Parasite), Dengue NS-1Timepoint: Assessment will be done on baseline (day 0) and day 7th	—

Countries

India

Contacts

Public ContactDr Anbuselvam A

Parul Institute of Ayurved

dr.manurajgopal@gmail.com9481328930

Outcome results